Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence.
- DOI
- 10.1111/imj.70604
- Published
- 2026 Aug 16
- Container
- Internal medicine journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/imj.70604,
title = {Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence.},
author = {Gondal F and Terlato M and Salehi O and Pillay L and Rentsch C and Dimovski S and Abasszade JH and Macrae F and Segal JP},
year = {2026},
journal = {Internal medicine journal},
doi = {10.1111/imj.70604},
url = {https://doi.org/10.1111/imj.70604}
}RIS
TY - JOUR TI - Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence. AU - Gondal F AU - Terlato M AU - Salehi O AU - Pillay L AU - Rentsch C AU - Dimovski S AU - Abasszade JH AU - Macrae F AU - Segal JP PY - 2026 JO - Internal medicine journal DO - 10.1111/imj.70604 UR - https://doi.org/10.1111/imj.70604 ER -
APA
F, G., M, T., O, S., L, P., C, R., S, D., JH, A., F, M., & JP, S. (2026). Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence.. Internal medicine journal. https://doi.org/10.1111/imj.70604
Source records
- pubmed · retrieved 2026-09-26T12:42:47.651Z